Updated February 2026Active Litigation

NEC Baby Formula (Similac/Enfamil) Lawsuit Tracker

Check Your Eligibility
Active LitigationLast updated: February 20, 2026

Necrotizing Enterocolitis is one of the most catastrophic diseases affecting premature infants in the United States, striking approximately 12% of very-low-birthweight babies and carrying a mortality rate of 20-30%. Medical research spanning more than two decades has consistently linked cow's milk-based premature infant formula — particularly Similac Special Care (Abbott Laboratories) and Enfamil Premature (Mead Johnson/Reckitt) — to dramatically elevated NEC risk in preterm infants. Studies show that premature infants fed cow's milk-based formula are three to ten times more likely to develop NEC than those fed human breast milk or pasteurized donor breast milk. Despite this well-established scientific evidence and the recommendations of the American Academy of Pediatrics, Abbott and Mead Johnson continued to aggressively market their formula products to NICUs for use in the most vulnerable patient population in medicine. Thousands of families across the country have filed suit against these manufacturers, and the cases are now consolidated in Multi-District Litigation (MDL 3026) in the United States District Court for the Northern District of Illinois, before the Honorable Rebecca R. Pallmeyer. Families who lost a baby to NEC or whose infant survived with lasting harm deserve answers, accountability, and financial compensation for their loss.

Case Timeline

Litigation Timeline

Months to Years After Filing

MDL Proceedings and Case Resolution

The case proceeds through MDL No. 3026 in the Northern District of Illinois. Discovery is coordinated — depositions of Abbott and Mead Johnson corporate representatives, medical expert disclosures, and document productions. Bellwether trials test the evidence before representative juries, producing verdicts that inform settlement negotiations across all cases in the MDL. Individual cases may resolve through negotiated settlement before or after bellwether trials. Cases not settled may be remanded to their home districts for individual trial. The MDL process is ongoing as of early 2026, with settlement discussions actively proceeding following significant plaintiff bellwether verdicts.

legal
After Discharge — When Family Is Ready

Filing Lawsuit Against Abbott and Mead Johnson

After the acute crisis — whether the infant survived or died — families seek legal counsel. An attorney with NEC MDL experience evaluates the case, obtains NICU medical records and feeding logs, retains expert neonatologists and pediatric surgeons, and files suit against Abbott Laboratories (Similac) and/or Mead Johnson/Reckitt (Enfamil) in the appropriate federal court. Most cases are filed in federal court and transferred to the MDL in the Northern District of Illinois. A Long Form Complaint specific to the family's facts is filed in the MDL. Important: for families whose infants survived, the minor tolling rule protects the child's claim — but parents filing their own loss-of-consortium claims are subject to the adult SOL and should contact an attorney without delay.

legal
NICU Days 7–21 (Typical Onset)

NEC Diagnosis and Emergency Treatment

The infant develops signs of NEC: abdominal distension, bloody stools, feeding intolerance, apnea, and metabolic instability. Abdominal X-rays reveal pneumatosis intestinalis — gas in the bowel wall — confirming the NEC diagnosis. The medical team stops all feedings (NPO), begins intravenous antibiotics, and monitors for progression. In Stage III NEC with perforation or clinical deterioration, the neonatal surgeon performs emergency surgery: laparotomy with resection of the necrotic bowel, creation of a stoma, and eventual re-anastomosis. In the most severe cases, the infant may enter septic shock and the outcome is fatal.

medical
NICU Days 1–14

Cow's Milk-Based Formula Fed in the NICU

NICU staff administer Similac Special Care, Enfamil Premature, or another cow's milk-based premature infant formula — either as the sole nutrition source or as a supplement to limited mother's milk. Feeding logs (nursing flowsheets) document the name of the formula, the volume administered, and the frequency of each feeding. These records are critical evidence in any subsequent lawsuit. Formula feeding during this early NICU period, before the infant's gut has adapted, is the period of greatest NEC vulnerability.

medical
Day 1 — Birth

Premature Birth and NICU Admission

Your baby is born prematurely — often under 32 weeks gestation — and is immediately admitted to the Neonatal Intensive Care Unit (NICU). At this stage, your infant is extraordinarily vulnerable: the immune system is immature, the intestinal lining is permeable and incompletely developed, and the gut microbiome has not yet established. If mother's own milk (MOM) is unavailable or insufficient, the NICU will typically begin formula supplementation. The type of formula administered at this critical window — human-milk-based or cow's milk-based — is one of the most consequential medical decisions of your baby's early life.

medical
Case Results

Notable Verdicts & Settlements

Jury Verdict
$495,000,000

Gill v. Mead Johnson & Company, LLC (St. Louis County, MO)

A Missouri state court jury awarded $495 million — including $490 million in punitive damages — to the family of a premature infant who developed NEC and died after being fed Enfamil Premature formula in the NICU. The verdict reflected the jury's finding that Mead Johnson acted with reckless disregard for the safety of premature infants and failed to adequately warn of the NEC risk. The verdict was one of the first major jury verdicts in NEC formula litigation and sent a powerful message to the industry. Post-trial proceedings and appellate review followed.

2022-10-13St. Louis County, Missouri
Stay informed

Get free updates on the NEC Baby Formula (Similac/Enfamil) as it develops

No phone call required. We will email you when there is meaningful news — new filings, settlements, or important deadlines.

By submitting, you agree to receive email updates about this case. You can unsubscribe anytime. This is not legal advice, and we are not a law firm.

Full Case Details

Want the Complete Picture?

View eligibility criteria, settlement information, scientific evidence, and start a free case review.

View Full NEC Baby Formula (Similac/Enfamil) Case Page